Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck 2024 Restructuring Program (Supply Network & Commercial Optimization) — Total Period Charges Incurred ($M) ($M)
Form 10-Q / 10-K Restructuring Footnote
Latest, Q2 2026
162
Period ended Jun 30, 2026
Change on a year earlier
+24.6%
130 in Q2 2025
History
10 quarters
Since Q1 2024
Sources
6
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | 2024 Restructuring Program (Supply Network & Commercial Optimization) — Total Period Charges Incurred ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 162 | +24.6% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 148 | +41.0% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 216 | +15.5% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 88 | -68.5% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 130 | -26.6% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2025 | Mar 31, 2025 | 105 | -57.3% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2024 | Dec 31, 2024 | 187 | – | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2024 | Sep 30, 2024 | 279 | – | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2024 | Jun 30, 2024 | 177 | – | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 246 | – | Form 10-Q (filed 2025-05-02) ↗ |
Breakdown
What makes up 2024 restructuring program (supply network & commercial optimization) — total period charges incurred ($m)
- 2024 Restructuring Program (Supply Network & Commercial Optimization) — Expected Total Program Cost ($M)4,000 · Q2 2026
- 2024 Restructuring Program (Supply Network & Commercial Optimization) — Cumulative Charges Incurred Since Inception ($M)1,900 · Q2 2026
- 2024 Restructuring Program (Supply Network & Commercial Optimization) — Ending Accrual Reserve Balance ($M)408 · Q2 2026
- 2024 Restructuring Program (Supply Network & Commercial Optimization) — Recorded in Cost of Sales ($M)99 · Q2 2026
- 2024 Restructuring Program (Supply Network & Commercial Optimization) — Recorded in Restructuring Line Item ($M)63 · Q2 2026
Cite this data
StockData. (2026). Merck 2024 Restructuring Program (Supply Network & Commercial Optimization) — Total Period Charges Incurred ($M) ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/restr_program2024_incurred
See every metric in the Merck KPI table. Data updated Oct 26, 2026.